If we backed out all of Pfizer’s projected COVID sales, its revenue would be in the ballpark of $52 billion next year. That would give the stock a forward P/S ratio of around 3.08, excluding COVID …
Could Pfizer Be a No-Brainer Stock to Buy Right Now, Even If Its COVID Sales Continue to Plunge?
Could Pfizer Be a No-Brainer Stock to Buy Right Now, Even If Its COVID Sales Continue to Plunge?
Leave a reply